Chronic Lyme disease: the controversies and the science

被引:0
|
作者
Lantos, Paul M. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Internal Med, Div Pediat Infect Dis,Hosp Med Program, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis,Hosp Med Program, Durham, NC 27710 USA
关键词
Borrelia burgdorferi; chronic fatigue; chronic Lyme disease; fibromyalgia; Lyme disease; BORRELIA-BURGDORFERI DNA; CHRONIC-FATIGUE-SYNDROME; CD57 LYMPHOCYTE SUBSET; ANTIBIOTIC-TREATMENT; ORAL DOXYCYCLINE; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; PENICILLIN-G; NEUROLOGIC MANIFESTATIONS; CEFTRIAXONE THERAPY;
D O I
10.1586/ERI.11.63
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The diagnosis of chronic Lyme disease has been embroiled in controversy for many years. This is exacerbated by the lack of a clinical or microbiologic definition, and the commonality of chronic symptoms in the general population. An accumulating body of evidence suggests that Lyme disease is the appropriate diagnosis for only a minority of patients in whom it is suspected. In prospective studies of Lyme disease, very few patients go on to have a chronic syndrome dominated by subjective complaints. There is no systematic evidence that Borrelia burgdorferi, the etiology of Lyme disease, can be identified in patients with chronic symptoms following treated Lyme disease. Multiple prospective trials have revealed that prolonged courses of antibiotics neither prevent nor alleviate such post-Lyme syndromes. Extended courses of intravenous antibiotics have resulted in severe adverse events, which in light of their lack of efficacy, make them contraindicated.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 50 条